The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 5, 2004, Pages 592-604

  Corcoran, Tomas B ^a,b   Engel, Arnth ^a   Sakamoto, Hidetoshi ^a   O'Callaghan Enright, Sheila ^a   O'Donnell, Aonghus ^a   Heffron, James A ^a   Shorten, George ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

cardiopulmonary bypass; cytokines; inflammation; myocardial ischemia reperfusion injury; oxygen derived free radicals

Indexed keywords

BETA2 INTEGRIN; DIPRIFUSOR; FENTANYL; FREE RADICAL; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; ISOFLURANE; MALONALDEHYDE; PANCURONIUM; PROPOFOL; SODIUM CHLORIDE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; CORONARY SINUS BLOOD FLOW; DRUG BLOOD LEVEL; ELECTIVE SURGERY; FEMALE; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HUMAN; INFLAMMATION; LEUKOCYTE FUNCTION; LIPID PEROXIDATION; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RESPIRATORY BURST; STABLE ANGINA PECTORIS;

AGED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANTI-INFLAMMATORY AGENTS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; ISOFLURANE; LEUKOCYTES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PROPOFOL; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS;

EID: 5644235357     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.07.018     Document Type: Article

References (42)

1. Park J.L., Lucchesi B.R. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 68:1999;1905-1912
2. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. Am J Med. 109:2000;315-323
3. Kirklin J.K. The postperfusion syndrome Inflammation and the damaging effects of cardiopulmonary bypass. Tiklin J.H. Cardiopulmonary Bypass Current Concepts and Controversies. 1989;131 Saunders, Philadelphia, PA
4. Breisblatt W.M., Stein K.L., Wolfe C.J., et al. Acute myocardial dysfunction and recovery A common occurrence after coronary bypass surgery. J Am Coll Card. 15:1990;1261-1269
5. Weman S.M., Karhunen P.J., Penttila A., et al. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg. 70:2000;807-812
6. Kersten J.R., Schmeling T.J., Hettrick D.A., et al. Mechanism of myocardial protection by isoflurane Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology. 85:1996;794-807
7. Murphy P.G., Myers D.S., Davies M.J., et al. The antioxidant potential of propofol. Br J Anesth. 68:1992;613-618
8. Musacchio E., Rizzoli V., Bianchi M., et al. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol. 69:1991;75-77
9. Bao Y.P., Williamson G., Tew D., et al. Antioxidant effects of propofol in human hepatic microsomes Concentration effects and clinical relevance. Br J Anaesth. 81:1998;584-589
10. Petros A.J., Bogle R.G., Pearson J.D. Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells. Br J Pharm. 109:1993;6-7
11. Mathy-Hartert M., Mouithys-Mickalad A., Kohnen S., et al. Effects of propofol on endothelial cells subjected to a peroxynitrite donor(SIN-1). Anaesthesia. 55:2000;1066-1071
12. Mikawa K., Akamatsu H., Nishina K., et al. Propofol inhibits human neutrophil functions. Anaesth Analg. 87:1998;695-700
13. Bull A.W., Marnett L.J. Determination of malondialdehyde by ion-pairing high-performance liquid chromatography. Analytical Biochem. 149:1985;284-290
14. Hess M.L., Manson N.H. Molecular oxygen friend and foe-the role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol. 16:1984;969-985
15. Kokita N., Hara A., Abiko Y., et al. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg. 86:1998;252-258
16. Bolli R., McCay P.B. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion A new approach to assessing the role of oxygen radicals in myocardial "stunning" Free Radical Res Commun. 9:1990;169-180
17. Bolli R., Jeroudi M.O., Patel B.S., et al. Marked reduction of free-radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res. 65:1989;607-622
18. Lazzarino G., Raatikainen P., Nuutinen M., et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation. 90:1994;291-297
19. De La Cruz J.P., Sedeno G., Carmona J.A., et al. The in-vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg. 87:1998;1141-1146
20. Mouithys-Mickalad A., Hans P., Deby-Dupont G., et al. Propofol reacts with peroxynitrite to form a phenoxyl radical Demonstration by electron spin resonance. Biochem Biophys Res Commun. 249:1998;833-837
21. Kokita N., Hara A. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangement in the isolated rat heart. Anesthesiology. 84:1996;117-127
22. Yoo K.Y., Yang S.Y., Lee J., et al. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth. 82:1999;90-96
23. Ebel D., Schlack W., Comfere T., et al. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth. 83:1999;903-908
24. Mathur S., Farhangkhgoee P., Karmazyn M. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts Role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology. 91:1999;1349-1360
25. Meissner A., Weber T.P., Van Aken H., et al. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs. Anesth Analg. 91:2000;1333-1338
26. De Hert S.G., ten Broecke P.W., Mertens E., et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 97:2002;42-49
27. Javadov S.A., Lim K.H., Kerr P.M., et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 45:2000;360-369
28. Cheng Y.J., Wang Y.P., Chien C.T., et al. Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia. Anesth Analg. 94:2002;1617-1620
29. Hall R.I., Smith M.S., Rocker G. The systemic inflammatory response to cardiopulmonary bypass Pathophysiological, therapeutic and pharmacological considerations. Anesth Analg. 85:1997;766-782
30. Burns S.A., Newburger J.W., Xiao M., et al. Induction of interleukin-8 mRNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation. 92:(suppl 2):1995;315-321
31. Kukielka G.L., Smith C.W., Manning A.M., et al. Induction of Interleukin 6 synthesis in the myocardium Potential role in postreperfusion inflammatory injury. Circulation. 92:1995;1866-1875
32. Chandrasekar B., Mitchell D.H., Colston J.T., et al. Regulation of CCAAT/enhancer binding protein, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation. 99:1999;427-433
33. Whitten C.W., Hill G.E., Ivy R., et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood products administered, influence the Il-6 response to cardiac surgery? Anaesth Analg. 86:1998;28-33
34. Hennein H.A., Ebba H., Rodriguez J.L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularisation. J Thorac Card Surg. 108:(4):1994;626-635
35. Sawa Y., Shimazaki Y., Kadoba K., et al. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg. 111:1996;29-35
36. Wan S., DeSmet J.M., Barvais L., et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811
37. Zahler S., Massoudy P., Hartl H., et al. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res. 41:1999;722-730
38. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 43:1999;860-878
39. Galinanes M., Watson C., Trivedi U., et al. Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation. 94:(suppl 2):1996;II364-II369
40. Elwatidy A.M., Fadalah M.A., Bukhari E.A., et al. Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG. Ann Thorac Surg. 68:1999;447-453
41. Ceconi C., Cargnoni A., Pasini E., et al. Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol. 260:1991;H1057-H1061
42. Mathy-Hartert M., Deby-Dupont G., Hans P., et al. Protective activity of propofol, diprivan and intralipid against active oxygen species. Mediators Inflamm. 7:1998;327-333